Cardiac device maker VytronUS raises another $11M
VytronUS, a medical device startup that remains secretive about its product, has raised another $11 million in its first round of funding, according to VentureWire. That new money, from existing investors Delphi Ventures and New Enterprise Associates, brings the total amount raised to $17 million.
The Sunnyvale, Calif., company says it’s developing a cardiovascular device that’s entering animal trials, but isn’t offering more details.
Life sciences briefing: Monday, Aug. 20, 2007
(UPDATED at 7:10pm PT: See below.)
Featured companies: NeurAxon, VytronUS, Avila Therapeutics, CardioNet, Ventana Medical Systems, CytoLogix, PlaCor
NeurAxon raises $32M for pain drugs — You have to hand it to Waltham, Mass.-based NeurAxon — the company certainly knows how to keep itself in the news. Today, it announced it has raised $32 million in a second funding round, a week after it reported a positive early-stage trial result for its experimental migraine treatment.
Investors included Delphi Ventures, OrbiMed Advisors,… Continue Reading